<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1518">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05141396</url>
  </required_header>
  <id_info>
    <org_study_id>1051681</org_study_id>
    <secondary_id>U01HL159878</secondary_id>
    <nct_id>NCT05141396</nct_id>
  </id_info>
  <brief_title>Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)</brief_title>
  <acronym>TEACH</acronym>
  <official_title>Implementation of Coordinated Spontaneous Awakening and Breathing Trials Using Telehealth-Enabled, Real-Time Audit and Feedback for Clinician Adherence: A Type II Hybrid Effectiveness-Implementation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intermountain Health Care, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Intermountain Health Care, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to evaluate if augmenting a usual audit and feedback&#xD;
      implementation approach with telehealth-enabled support improves coordinated spontaneous&#xD;
      awakening/breathing trials and patient outcomes for mechanically ventilated patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sedation and analgesia are utilized with invasive mechanical ventilation (IMV) to improve&#xD;
      patient comfort and synchrony with the mechanical ventilator. Prolonged sedation, however,&#xD;
      may result in increased time on IMV and increased risk for ventilator associated pneumonia,&#xD;
      delirium, and poor long-term cognitive outcomes. Daily interruptions in sedation [spontaneous&#xD;
      awakening trials (SAT)] coordinated with daily spontaneous breathing trials (SBT) reduce&#xD;
      mortality, increase ventilator free days, decrease intensive care unit (ICU) length of stay,&#xD;
      and reduces ventilator-associated events. Coordination of spontaneous awakening and breathing&#xD;
      trials (C-SAT/SBT), however, are underutilized due to significant barriers to implementation&#xD;
      and adherence. This cluster-randomized hybrid implementation/effectiveness trial will compare&#xD;
      C-SAT/SBT adherence and clinical outcomes in the presence of traditional audit and feedback&#xD;
      implementation strategies alone or augmented with a novel Telehealth-Enabled, real-time Audit&#xD;
      and feedback for Clinician adHerence (&quot;TEACH&quot;) implementation strategy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">October 15, 2026</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence to C-SAT/SBT</measure>
    <time_frame>intubation to extubation - an average of 5 days</time_frame>
    <description>Fraction of eligible days on which coordinated spontaneous awakening trial and spontaneous breathing trial completed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ventilator-free days to day 28</measure>
    <time_frame>28 days</time_frame>
    <description>ventilator-free days to day 28</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>30-day Mortality</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Length of Stay</measure>
    <time_frame>Through hospital discharge, an average of 10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>90-day Mortality</measure>
    <time_frame>90 Days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New ventilator-associated pneumonia</measure>
    <time_frame>Through hospital discharge, an average of 10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU Length of Stay</measure>
    <time_frame>Through hospital discharge, an average of 10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reintubation</measure>
    <time_frame>intubation to extubation - an average of 5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unintentional Extubation</measure>
    <time_frame>intubation to extubation - an average of 5 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">13400</enrollment>
  <condition>Respiration, Artificial</condition>
  <arm_group>
    <arm_group_label>Intervention - Telehealth- enabled support plus usual audit and feedback for SAT/SBT adherence</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Usual audit and feedback + telehealth-enabled support</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control - Usual audit/feedback for SAT/SBT adherence only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual audit and feedback</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Telehealth- enabled support for SAT/SBT adherence</intervention_name>
    <description>Telehealth-enabled support over and above usual audit and feedback includes identifying candidates for spontaneous awakening and breathing trials, prompting bedside providers and guiding execution of the coordinated spontaneous awakening and breathing trials as needed.</description>
    <arm_group_label>Intervention - Telehealth- enabled support plus usual audit and feedback for SAT/SBT adherence</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual audit and feedback for SAT/SBT adherence</intervention_name>
    <description>Usual audit and feedback</description>
    <arm_group_label>Control - Usual audit/feedback for SAT/SBT adherence only</arm_group_label>
    <arm_group_label>Intervention - Telehealth- enabled support plus usual audit and feedback for SAT/SBT adherence</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Patient age &gt;=16 years admitted to study hospital ICU&#xD;
&#xD;
          -  Intubated and mechanically ventilated&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Patient with pre-existing brain death admitted to study hospital for organ donation&#xD;
&#xD;
          -  Died within 24 hours of intubation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Colin Grissom, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Intermountain Health Care, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carlos Barbagelata</last_name>
    <phone>8015074607</phone>
    <email>carlos.barbagelata@imail.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Colin Grissom, MD</last_name>
    <phone>801-507-6554</phone>
    <email>colin.grissom@imail.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>American Fork Hospital</name>
      <address>
        <city>American Fork</city>
        <state>Utah</state>
        <zip>84003</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>David Guidry, MD</last_name>
    </contact>
    <investigator>
      <last_name>David Guidry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cedar City Hospital</name>
      <address>
        <city>Cedar City</city>
        <state>Utah</state>
        <zip>84721</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>David Guidry, MD</last_name>
    </contact>
    <investigator>
      <last_name>David Guidry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Layton Hospital</name>
      <address>
        <city>Layton</city>
        <state>Utah</state>
        <zip>84041</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>David Guidry, MD</last_name>
    </contact>
    <investigator>
      <last_name>David Guidry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Logan Regional Hospital</name>
      <address>
        <city>Logan</city>
        <state>Utah</state>
        <zip>84341</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>David Guidry, MD</last_name>
    </contact>
    <investigator>
      <last_name>David Guidry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Intermountain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Andrew Knighton</last_name>
      <phone>801-507-8714</phone>
      <email>Andrew.Knighton@imail.org</email>
    </contact>
    <investigator>
      <last_name>Colin Grissom, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Samuel Brown, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Perry Gee, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Guidry</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew Knighton</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lindsay Leither, DO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ithan Peltan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pallavi Ranade</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rajendu Srivastava</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mckay Dee Hospital</name>
      <address>
        <city>Ogden</city>
        <state>Utah</state>
        <zip>84403</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Colin Grissom, MD</last_name>
    </contact>
    <investigator>
      <last_name>Colin Grissom, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Utah Valley Hospital</name>
      <address>
        <city>Provo</city>
        <state>Utah</state>
        <zip>84604</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Colin Grissom, MD</last_name>
    </contact>
    <investigator>
      <last_name>Colin Grissom, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Riverton Hospital</name>
      <address>
        <city>Riverton</city>
        <state>Utah</state>
        <zip>84065</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>David Guidry, MD</last_name>
    </contact>
    <investigator>
      <last_name>David Guidry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. George Regional Hospital</name>
      <address>
        <city>Saint George</city>
        <state>Utah</state>
        <zip>84790</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Colin Grissom, MD</last_name>
    </contact>
    <investigator>
      <last_name>Colin Grissom, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>LDS Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84143</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Colin Grissom, MD</last_name>
    </contact>
    <investigator>
      <last_name>Colin Grissom, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alta View Hospital</name>
      <address>
        <city>Sandy</city>
        <state>Utah</state>
        <zip>84094</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>David Guidry, MD</last_name>
    </contact>
    <investigator>
      <last_name>David Guidry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 19, 2021</study_first_submitted>
  <study_first_submitted_qc>November 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2021</study_first_posted>
  <last_update_submitted>November 19, 2021</last_update_submitted>
  <last_update_submitted_qc>November 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Invasive Mechanical Ventilation</keyword>
  <keyword>Coordinated Spontaneous Awakening and Breathing Trials</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>In order to protect patient privacy and comply with relevant regulations, identified data will be unavailable. Requests for deidentified data from qualified researchers with appropriate ethics board approvals and relevant data use agreements will be processed by the Intermountain Office of Research, officeofresearch@imail.org.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

